This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions

This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions

Source: 
Forbes
snippet: 

Benjamin Oakes' Scribe Therapeutics is developing specialized Crispr proteins for multiple diseases–and it’s got deals with Big Pharma potentially worth over $4 billion